Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Breast Cancer

Free Subscription Articles published in J Clin Oncol Retrieve available abstracts of 235 articles: HTML format Text format

Single Articles

March 2010
1. STAAF J , Ringner M, Vallon-Christersson J, Jonsson G, et al
   Identification of Subtypes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. CAUDLE AS , Gonzalez-Angulo AM, Hunt KK, Liu P, et al
   Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. EICHHORN PJ , Baselga J
   HER2 Signatures in Breast Cancer: Ready to Go to Print?
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles   
   
   
   
4. DOWSETT M , Cuzick J, Wale C, Forbes J, et al
   Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. TAN MH , Leo NQ, Loy EY, Lim WY, et al
   Association Between Being Underweight and Outcomes in Breast Cancer: Alternative Explanations.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles   
   
   
   
6. VODUC KD , Cheang MC, Tyldesley S, Gelmon K, et al
   Breast Cancer Subtypes and the Risk of Local and Regional Relapse.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. SAAD ED , Katz A, Buyse M
   Overall Survival and Post-Progression Survival in Advanced Breast Cancer: A Review of Recent Randomized Clinical Trials.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. MOON HG , Han W, Noh DY
   Comparable Survival Between pN0 Breast Cancer Patients Undergoing Sentinel Node Biopsy and Extensive Axillary Dissection: A Report From the Korean Breast Cancer Society.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. GRENADER T , Gabizon A
   What Is the Right Way to Administer Pegylated Liposomal Doxorubicin in Breast Cancer Therapy?
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles   
   
   
   
10. HAFFTY BG , Buchholz TA
    Molecular Predictors of Locoregional Recurrence in Breast Cancer: Ready for Prime Time?
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    February 2010
11. UNTCH M , Muscholl M, Tjulandin S, Jonat W, et al
    First-Line Trastuzumab Plus Epirubicin and Cyclophosphamide Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Cardiac Safety and Efficacy Data From the Herceptin, Cyclophosphamide, and Epirubicin (HER
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. KUHL C , Weigel S, Schrading S, Arand B, et al
    Prospective Multicenter Cohort Study to Refine Management Recommendations for Women at Elevated Familial Risk of Breast Cancer: The EVA Trial.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. KLIJN JG
    Early Diagnosis of Hereditary Breast Cancer by Magnetic Resonance Imaging: What Is Realistic?
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
14. HOLMES MD , Chen WY, Li L, Hertzmark E, et al
    Aspirin Intake and Survival After Breast Cancer.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. FRIEDENREICH CM , Woolcott CG, McTiernan A, Ballard-Barbash R, et al
    Alberta Physical Activity and Breast Cancer Prevention Trial: Sex Hormone Changes in a Year-Long Exercise Intervention Among Postmenopausal Women.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. GOMEZ SL , Lichtensztajn D, Kurian AW, Telli ML, et al
    Increasing Mastectomy Rates for Early-Stage Breast Cancer? Population-Based Trends From California.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
17. GYORKI DE , Henderson MA
    Significance of Sentinel Lymph Node Micrometastases in Patients With Breast Cancer.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
18. VAN DIEST PJ , de Boer M, van Deurzen CH, Tjan-Heijnen VC, et al
    Micrometastases and Isolated Tumor Cells in Breast Cancer Are Indeed Associated With Poorer Outcome.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
19. CHLEBOWSKI RT
    Lifestyle and Breast Cancer Risk: The Way Forward?
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
20. SANGHANI M , Truong PT, Raad RA, Niemierko A, et al
    Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy.
    J Clin Oncol. 2010;28:718-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. SOLIN LJ
    Breast conservation treatment with radiation: an ongoing success story.
    J Clin Oncol. 2010;28:709-11.
    PubMed     Text format     Related articles   
    
    
    
22. SCHILDER CM , Seynaeve C, Beex LV, Boogerd W, et al
    Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. BURSTEIN HJ , Sun Y, Dirix LY, Jiang Z, et al
    Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Breast Cancer.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. BLACKWELL KL , Burstein HJ, Storniolo AM, Rugo H, et al
    Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. DUNBIER AK , Anderson H, Ghazoui Z, Folkerd EJ, et al
    Relationship Between Plasma Estradiol Levels and Estrogen-Responsive Gene Expression in Estrogen Receptor-Positive Breast Cancer in Postmenopausal Women.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. GIANNI L , Llado A, Bianchi G, Cortes J, et al
    Open-Label, Phase II, Multicenter, Randomized Study of the Efficacy and Safety of Two Dose Levels of Pertuzumab, a Human Epidermal Growth Factor Receptor 2 Dimerization Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2-Negative Meta
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. BASELGA J , Gelmon KA, Verma S, Wardley A, et al
    Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. TSOI DT , Rowsell C, McGregor C, Kelly CM, et al
    Disseminated Tumor Embolism From Breast Cancer Leading to Multiorgan Failure.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
29. GREWAL J , Zhou H, Factor R, Kesari S, et al
    Isolated Loss of Hormonal Receptors in Leptomeningeal Metastasis From Estrogen Receptor- and Progesterone Receptor-Positive Lobular Breast Cancer.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
30. KIYOTANI K , Mushiroda T, Imamura CK, Hosono N, et al
    Significant Effect of Polymorphisms in CYP2D6 and ABCC2 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Breast Cancer Patients.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. CHU QD , Glass J
    Findings that hospital factors are surrogate for disparities are misleading.
    J Clin Oncol. 2010;28:e56.
    PubMed     Text format     Related articles   
    
    
    January 2010
32. SILVER DP , Richardson AL, Eklund AC, Wang ZC, et al
    Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. CREW KD , Capodice JL, Greenlee H, Brafman L, et al
    Randomized, Blinded, Sham-Controlled Trial of Acupuncture for the Management of Aromatase Inhibitor-Associated Joint Symptoms in Women With Early-Stage Breast Cancer.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. LI CI , Mathes RW, Bluhm EC, Caan B, et al
    Migraine History and Breast Cancer Risk Among Postmenopausal Women.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. SMITH TJ , Hillner BE
    Comment on Pegylated Liposomal Doxorubicin Plus Docetaxel in Metastatic Breast Cancer.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
36. LO SS , Mumby PB, Norton J, Rychlik K, et al
    Prospective Multicenter Study of the Impact of the 21-Gene Recurrence Score Assay on Medical Oncologist and Patient Adjuvant Breast Cancer Treatment Selection.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. MAMOUNAS EP , Tang G, Fisher B, Paik S, et al
    Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. ARENA V , Pennacchia I, Monego G, Carbone A, et al
    Fluorescent in Situ Hybridization As a Primary Test for HER2 Status in Breast Cancer: Controversies.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
39. NAINA HV , Patnaik MM, Ali UA, Chen D, et al
    Systemic Fibrinolysis Caused by Tissue Plasminogen Activator-Producing Metastatic Breast Cancer.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
40. SPARANO JA , Solin LJ
    Defining the Clinical Utility of Gene Expression Assays in Breast Cancer: The Intersection of Science and Art in Clinical Decision Making.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
41. CHEN X , Lu W, Zheng Y, Gu K, et al
    Exercise, Tea Consumption, and Depression Among Breast Cancer Survivors.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
42. WARDLEY AM , Pivot X, Morales-Vasquez F, Zetina LM, et al
    Randomized Phase II Trial of First-Line Trastuzumab Plus Docetaxel and Capecitabine Compared With Trastuzumab Plus Docetaxel in HER2-Positive Metastatic Breast Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. STRAVER ME , Meijnen P, van Tienhoven G, van de Velde CJ, et al
    Role of Axillary Clearance After a Tumor-Positive Sentinel Node in the Administration of Adjuvant Therapy in Early Breast Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. WALKER EM , Rodriguez AI, Kohn B, Ball RM, et al
    Acupuncture Versus Venlafaxine for the Management of Vasomotor Symptoms in Patients With Hormone Receptor-Positive Breast Cancer: A Randomized Controlled Trial.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. EJLERTSEN B , Jensen MB, Nielsen KV, Balslev E, et al
    HER2, TOP2A, and TIMP-1 and Responsiveness to Adjuvant Anthracycline-Containing Chemotherapy in High-Risk Breast Cancer Patients.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. WONG NS , Buckman RA, Clemons M, Verma S, et al
    Phase I/II Trial of Metronomic Chemotherapy With Daily Dalteparin and Cyclophosphamide, Twice-Weekly Methotrexate, and Daily Prednisone As Therapy for Metastatic Breast Cancer Using Vascular Endothelial Growth Factor and Soluble Vascular Endothelial G
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. ARENA V , Pennacchia I, Carbone A
    Breast Cancer Pathology Report: In Response to Zurrida et al.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
48. CLOUGH-GORR KM , Stuck AE, Thwin SS, Silliman RA, et al
    Older Breast Cancer Survivors: Geriatric Assessment Domains Are Associated With Poor Tolerance of Treatment Adverse Effects and Predict Mortality Over 7 Years of Follow-Up.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. CAREY LA
    Targeted Chemotherapy? Platinum in BRCA1-Dysfunctional Breast Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
50. FISHER B , Anderson SJ
    The Breast Cancer Alternative Hypothesis: Is There Evidence to Justify Replacing It?
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
51. ANDERSON WF , Jatoi I, Tse J, Rosenberg PS, et al
    Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
52. DOWSETT M , Cuzick J, Ingle J, Coates A, et al
    Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. GARCIA A , Tisman G
    Metformin, B12 and Enhanced Breast Cancer Response to Chemotherapy.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
54. DAWOOD S , Broglio K, Buzdar AU, Hortobagyi GN, et al
    Prognosis of Women With Metastatic Breast Cancer by HER2 Status and Trastuzumab Treatment: An Institutional-Based Review.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. DENKERT C , Loibl S, Noske A, Roller M, et al
    Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. VOOGD AC , Nieuwenhuijzen GA, Coebergh JW
    Age-Related Variations in the Use of Axillary Staging May Explain the Increased Risk of Axillary Lymph Node Involvement in Older Women With Breast Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
57. MOLASSIOTIS A , Brearley S, Saunders M, Craven O, et al
    Effectiveness of a Home Care Nursing Program in the Symptom Management of Patients With Colorectal and Breast Cancer Receiving Oral Chemotherapy: A Randomized, Controlled Trial.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. SPIELMANN M , Roche H, Delozier T, Canon JL, et al
    Trastuzumab for Patients With Axillary-Node-Positive Breast Cancer: Results of the FNCLCC-PACS 04 Trial.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. GLUZ O , Mengele K, Schmitt M, Kates R, et al
    Y-Box-Binding Protein YB-1 Identifies High-Risk Patients With Primary Breast Cancer Benefiting From Rapidly Cycled Tandem High-Dose Adjuvant Chemotherapy.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. BURNELL M , Levine MN, Chapman JA, Bramwell V, et al
    Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. COSTA SD , Loibl S, Kaufmann M, Zahm DM, et al
    Neoadjuvant Chemotherapy Shows Similar Response in Patients With Inflammatory or Locally Advanced Breast Cancer When Compared With Operable Breast Cancer: A Secondary Analysis of the GeparTrio Trial Data.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. JOENSUU H , Bono P, Kataja V, Alanko T, et al
    Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. CURIGLIANO G , Viale G, Bagnardi V, Fumagalli L, et al
    Clinical Relevance of HER2 Overexpression/Amplification in Patients With Small Tumor Size and Node-Negative Breast Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. SPECTOR NL , Blackwell KL
    Understanding the Mechanisms Behind Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. AUTIER P , Hery C, Haukka J, Boniol M, et al
    Advanced Breast Cancer and Breast Cancer Mortality in Randomized Controlled Trials on Mammography Screening.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. GONZALEZ-ANGULO AM , Litton JK, Broglio KR, Meric-Bernstam F, et al
    High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2-Positive, Node-Negative Tumors 1 cm or Smaller.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. BURSTEIN HJ , Winer EP
    Refining Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: T Stands for Trastuzumab, Tumor Size, and Treatment Strategy.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
68. SANCHEZ-MUNOZ A , Ribelles N, Marquez A, Perez-Ruiz E, et al
    Aromatase Inhibitors As Adjuvant Therapy for Breast Cancer: Overall Survival Versus Disease-Free Survival As a Primary End Point in Clinical Practice.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
69. GRENADER T , Goldberg A, Shavit L
    Metformin As an Addition to Conventional Chemotherapy in Breast Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    October 2009
70. GRAESER MK , Engel C, Rhiem K, Gadzicki D, et al
    Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. FINN RS , Gagnon R, Di Leo A, Press MF, et al
    Prognostic and Predictive Value of HER2 Extracellular Domain in Metastatic Breast Cancer Treated With Lapatinib and Paclitaxel in a Randomized Phase III Study.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. TRUDEAU ME , Clemons MJ, Provencher L, Panasci L, et al
    Phase II Multicenter Trial of Anthracycline Rechallenge With Pegylated Liposomal Doxorubicin Plus Cyclophosphamide for First-Line Therapy of Metastatic Breast Cancer Previously Treated With Adjuvant Anthracyclines.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. GARBER JE , Golshan M
    Contralateral Breast Cancer in BRCA1/BRCA2 Mutation Carriers: The Story of the Other Side.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
74. TRAINA TA , Rugo HS, Caravelli JF, Patil S, et al
    Feasibility Trial of Letrozole in Combination With Bevacizumab in Patients With Metastatic Breast Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. ARENA V , Pennacchia I, Monego G, Carbone A, et al
    Breast Cancer Classification: The Dialogue Is Open.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
76. WERKOFF G , Lambaudie E, Fondrinier E, Leveque J, et al
    Prospective Multicenter Comparison of Models to Predict Four or More Involved Axillary Lymph Nodes in Patients With Breast Cancer With One to Three Metastatic Sentinel Lymph Nodes.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. PONZONE R , Tomasi Cont N, Maggiorotto F, Cassina E, et al
    Extensive Nodal Disease May Impair Axillary Reverse Mapping in Patients With Breast Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. ANDERSON WF , Jatoi I, Sherman ME
    Qualitative Age Interactions in Breast Cancer Studies: Mind the Gap.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
79. KHAN SA
    Axillary Reverse Mapping to Prevent Lymphedema After Breast Cancer Surgery: Defining the Limits of the Concept.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
80. MCKIAN KP , Reynolds CA, Visscher DW, Nassar A, et al
    Novel Breast Tissue Feature Strongly Associated With Risk of Breast Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. BRENNAN ME , Houssami N, Lord S, Macaskill P, et al
    Magnetic Resonance Imaging Screening of the Contralateral Breast in Women With Newly Diagnosed Breast Cancer: Systematic Review and Meta-Analysis of Incremental Cancer Detection and Impact on Surgical Management.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. MOON HG , Han W, Noh DY
    Underweight and Breast Cancer Recurrence and Death: A Report From the Korean Breast Cancer Society.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
83. KAUFMAN B , Mackey JR, Clemens MR, Bapsy PP, et al
    Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. JOHNSTON S , Pippen J Jr, Pivot X, Lichinitser M, et al
    Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor-Positive Metastatic Breast Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. CORTES J , Baselga J
    How to Treat Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Amplified Breast Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
86. LEYLAND-JONES B
    Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Central Nervous System Metastases.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. BICKELL NA , Weidmann J, Fei K, Lin JJ, et al
    Underuse of Breast Cancer Adjuvant Treatment: Patient Knowledge, Beliefs, and Medical Mistrust.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. LIU MC , Shields PG, Warren RD, Cohen P, et al
    Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. FOURNIER A , Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F, et al
    Estrogen-Progestagen Menopausal Hormone Therapy and Breast Cancer: Does Delay From Menopause Onset to Treatment Initiation Influence Risks?
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. AMBROSONE CB , Barlow WE, Reynolds W, Livingston RB, et al
    Myeloperoxidase Genotypes and Enhanced Efficacy of Chemotherapy for Early-Stage Breast Cancer in SWOG-8897.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. BERNSTEIN L
    Combined Hormone Therapy at Menopause and Breast Cancer: A Warning--Short-Term Use Increases Risk.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
92. PUSZTAI L , Jeong JH, Gong Y, Ross JS, et al
    Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial.
    J Clin Oncol. 2009;27:4287-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. LI CI , Daling JR, Porter PL, Tang MT, et al
    Relationship Between Potentially Modifiable Lifestyle Factors and Risk of Second Primary Contralateral Breast Cancer Among Women Diagnosed With Estrogen Receptor-Positive Invasive Breast Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. CHANG DY , Lin CH, Lu YS
    Locoregional Therapy Improves Survival for Metastatic Breast Cancer Patients? Benefit Remains Questionable!
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
95. ABEL GA , Burstein HJ, Hevelone ND, Weeks JC, et al
    Cancer-related direct-to-consumer advertising: awareness, perceptions, and reported impact among patients undergoing active cancer treatment.
    J Clin Oncol. 2009;27:4182-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. MOSS J , Israel RJ
    Effects of anesthetics on cancer recurrence.
    J Clin Oncol. 2009;27:e89.
    PubMed     Text format     Related articles   
    
    
    
97. KATIPAMULA R , Degnim AC, Hoskin T, Boughey JC, et al
    Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging.
    J Clin Oncol. 2009;27:4082-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. MORROW M , Harris JR
    More mastectomies: is this what patients really want?
    J Clin Oncol. 2009;27:4038-40.
    PubMed     Text format     Related articles   
    
    
    August 2009
99. HANSEN NM , Grube B, Ye X, Turner RR, et al
    Impact of Micrometastases in the Sentinel Node of Patients With Invasive Breast Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. DISIS ML , Wallace DR, Gooley TA, Dang Y, et al
     Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. BRACHTEL EF , Rusby JE, Michaelson JS, Chen LL, et al
     Occult Nipple Involvement in Breast Cancer: Clinicopathologic Findings in 316 Consecutive Mastectomy Specimens.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. GRAY R , Bhattacharya S, Bowden C, Miller K, et al
     Independent Review of E2100: A Phase III Trial of Bevacizumab Plus Paclitaxel Versus Paclitaxel in Women With Metastatic Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. MILLAR EK , Graham PH, O'Toole SA, McNeil CM, et al
     Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker Panel.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. VAN BELLE V , Van Calster B, Wildiers H, Van Huffel S, et al
     Lymph Node Ratio Better Predicts Disease Free Survival in Node-Positive Breast Cancer Than the Number of Positive Lymph Nodes.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
105. HUO D , Ikpatt F, Khramtsov A, Dangou JM, et al
     Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. ROBERTSON JF , Llombart-Cussac A, Rolski J, Feltl D, et al
     Activity of Fulvestrant 500 mg Versus Anastrozole 1 mg As First-Line Treatment for Advanced Breast Cancer: Results From the FIRST Study.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. BOOTH CM , Le Maitre A, Ding K, Farn K, et al
     Presentation of nonfinal results of randomized controlled trials at major oncology meetings.
     J Clin Oncol. 2009;27:3938-44.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. RECHT A , Ancukiewicz M, Alm El-Din MA, Lu XQ, et al
     Lung dose-volume parameters and the risk of pneumonitis for patients treated with accelerated partial-breast irradiation using three-dimensional conformal radiotherapy.
     J Clin Oncol. 2009;27:3887-93.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. WATSON P , Lieberman R, Snyder C, Clark VJ, et al
     Detecting BRCA2 protein truncation in tissue biopsies to identify breast cancers that arise in BRCA2 gene mutation carriers.
     J Clin Oncol. 2009;27:3894-900.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. MUSALLAM KM , Jamali FR, Hatoum HA, Seoud M, et al
     Axillary lymph node ratio revisited.
     J Clin Oncol. 2009;27:e67.
     PubMed     Text format     Related articles   
     
     
     
111. BUIST DS , Chubak J, Prout M, Yood MU, et al
     Referral, Receipt, and Completion of Chemotherapy in Patients With Early-Stage Breast Cancer Older Than 65 Years and at High Risk of Breast Cancer Recurrence.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. CAAN BJ , Aragaki A, Thomson CA, Stefanick ML, et al
     Vasomotor Symptoms, Adoption of a Low-Fat Dietary Pattern, and Risk of Invasive Breast Cancer: A Secondary Analysis of the Women's Health Initiative Randomized Controlled Dietary Modification Trial.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. SPARANO JA , Makhson AN, Semiglazov VF, Tjulandin SA, et al
     Pegylated Liposomal Doxorubicin Plus Docetaxel Significantly Improves Time to Progression Without Additive Cardiotoxicity Compared With Docetaxel Monotherapy in Patients With Advanced Breast Cancer Previously Treated With Neoadjuvant-Adjuvant Anthracycli
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. ELLARD SL , Clemons M, Gelmon KA, Norris B, et al
     Randomized Phase II Study Comparing Two Schedules of Everolimus in Patients With Recurrent/Metastatic Breast Cancer: NCIC Clinical Trials Group IND.163.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. GIANNI L , Norton L, Wolmark N, Suter TM, et al
     Role of Anthracyclines in the Treatment of Early Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. MOHIUDDIN MM , Regine WF
     Consenting the Patient With Early-Stage Breast Cancer: "Informed" Only After Multi-Discliplinary Evaluation.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
117. DE BRUIN ML , Sparidans J, Van't Veer MB, Noordijk EM, et al
     Breast Cancer Risk in Female Survivors of Hodgkin's Lymphoma: Lower Risk After Smaller Radiation Volumes.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. CRUMP M , Hodgson D
     Secondary Breast Cancer in Hodgkin's Lymphoma Survivors.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
119. PANASCI LC
     Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
120. FABIAN CJ
     Surrogate response biomarkers in prevention research: do they point the way or lead us astray?
     J Clin Oncol. 2009;27:3734-6.
     PubMed     Text format     Related articles   
     
     
     
121. BEDARD PL , Body JJ, Piccart-Gebhart MJ
     Sowing the Soil for Cure? Results of the ABCSG-12 Trial Open a New Chapter in the Evolving Adjuvant Bisphosphonate Story in Early Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
122. SOONG D , Haj R, Leung MG, Myers R, et al
     High Rate of Febrile Neutropenia in Patients With Operable Breast Cancer Receiving Docetaxel and Cyclophosphamide.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
123. OLSON AC , Link JS, Waisman JR, Kupiec TC, et al
     Breast Cancer Patients Unknowingly Dosing Themselves With Estrogen by Using Topical Moisturizers.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     July 2009
124. FINN RS , Press MF, Dering J, Arbushites M, et al
     Estrogen Receptor, Progesterone Receptor, Human Epidermal Growth Factor Receptor 2 (HER2), and Epidermal Growth Factor Receptor Expression and Benefit From Lapatinib in a Randomized Trial of Paclitaxel With Lapatinib or Placebo As First-Line Treatment in
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. TUBBS R , Barlow WE, Budd GT, Swain E, et al
     Outcome of Patients With Early-Stage Breast Cancer Treated With Doxorubicin-Based Adjuvant Chemotherapy As a Function of HER2 and TOP2A Status.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. INSKIP PD , Robison LL, Stovall M, Smith SA, et al
     Radiation Dose and Breast Cancer Risk in the Childhood Cancer Survivor Study.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. PRITCHARD KI
     Are HER2 and TOP2A Useful As Prognostic or Predictive Biomarkers for Anthracycline-Based Adjuvant Chemotherapy for Breast Cancer?
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
128. CHLEBOWSKI RT
     Caution Regarding 25-Hydroxyvitamin D Monitoring in Women With Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
129. ESTEVA FJ , Hortobagyi GN
     Topoisomerase II{alpha} amplification and anthracycline-based chemotherapy: the jury is still out.
     J Clin Oncol. 2009;27:3416-7.
     PubMed     Text format     Related articles   
     
     
     
130. DECENSI A , Robertson C, Guerrieri-Gonzaga A, Serrano D, et al
     Randomized Double-Blind 2 x 2 Trial of Low-Dose Tamoxifen and Fenretinide for Breast Cancer Prevention in High-Risk Premenopausal Women.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. NEKHLYUDOV L , Habel LA, Achacoso NS, Jung I, et al
     Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery.
     J Clin Oncol. 2009;27:3211-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2009
132. KRIEGE M , Seynaeve C, Meijers-Heijboer H, Collee JM, et al
     Sensitivity to First-Line Chemotherapy for Metastatic Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. BALMANOUKIAN A , Zhang Z, Jeter S, Slater S, et al
     African American Women Who Receive Primary Anthracycline- and Taxane-Based Chemotherapy for Triple-Negative Breast Cancer Suffer Worse Outcomes Compared With White Women.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
134. MANN GB , Kang YC, Brand C, Ebeling PR, et al
     Secondary Causes of Low Bone Mass in Patients With Breast Cancer: A Need for Greater Vigilance.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. DOWSETT M , Procter M, McCaskill-Stevens W, de Azambuja E, et al
     Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial.
     J Clin Oncol. 2009;27:2962-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. HAYES SC , Janda M, Cornish B, Newman B, et al
     Lymphedema following breast cancer.
     J Clin Oncol. 2009;27:2890.
     PubMed     Text format     Related articles   
     
     
     
137. SMITH BD , Smith GL, Hurria A, Hortobagyi GN, et al
     Future of cancer incidence in the United States: burdens upon an aging, changing nation.
     J Clin Oncol. 2009;27:2758-65.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. SHI L , Dong B, Li Z, Lu Y, et al
     Expression of ER-{alpha}36, a Novel Variant of Estrogen Receptor {alpha}, and Resistance to Tamoxifen Treatment in Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. GRANT CS , Ingle JN, Suman VJ, Dumesic DA, et al
     Menstrual Cycle and Surgical Treatment of Breast Cancer: Findings From the NCCTG N9431 Study.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. JIRALERSPONG S , Palla SL, Giordano SH, Meric-Bernstam F, et al
     Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. FOWLER AM , Santen RJ, Allred DC
     "Dwarf" Estrogen Receptor in Breast Cancer and Resistance to Tamoxifen.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
142. GOODWIN PJ , Ligibel JA, Stambolic V
     Metformin in Breast Cancer: Time for Action.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
143. GUINEBRETIERE JM
     Cancer is heterogeneous.
     J Clin Oncol. 2009;27:2732.
     PubMed     Text format     Related articles   
     
     
     May 2009
144. HARRIS LN , Broadwater G, Abu-Khalaf M, Cowan D, et al
     Topoisomerase II{alpha} Amplification Does Not Predict Benefit From Dose-Intense Cyclophosphamide, Doxorubicin, and Fluorouracil Therapy in HER2-Amplified Early Breast Cancer: Results of CALGB 8541/150013.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. GRADISHAR WJ , Krasnojon D, Cheporov S, Makhson AN, et al
     Significantly Longer Progression-Free Survival With nab-Paclitaxel Compared With Docetaxel As First-Line Therapy for Metastatic Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. PIERCE BL , Ballard-Barbash R, Bernstein L, Baumgartner RN, et al
     Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. VISVANATHAN K , Chlebowski RT, Hurley P, Col NF, et al
     American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. COLE SW
     Chronic Inflammation and Breast Cancer Recurrence.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
149. ARENA V , Pennacchia I, Carbone A, Capelli A, et al
     Fluorescent In Situ Hybridization for Human Epidermal Growth Factor Receptor 2 Assessment in Breast Cancer: Is It Applicable As a Primary Test?
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
150. BRESLIN TM , Morris AM, Gu N, Wong SL, et al
     Hospital Factors and Racial Disparities in Mortality After Surgery for Breast and Colon Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. WILDIERS H , Van Calster B, van de Poll-Franse LV, Hendrickx W, et al
     Relationship Between Age and Axillary Lymph Node Involvement in Women With Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. KIMMICK G , Anderson R, Camacho F, Bhosle M, et al
     Adjuvant Hormonal Therapy Use Among Insured, Low-Income Women With Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
153. DE GIORGI U , Valero V, Rohren E, Dawood S, et al
     Circulating Tumor Cells and [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Outcome Prediction in Metastatic Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. GOODWIN PJ , Ennis M, Pritchard KI, Koo J, et al
     Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. MAMOUNAS EP
     Age and Lymph Node Status in Breast Cancer: Not a Straightforward Relationship.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
156. MEHTA RS , Jackson D, Schubbert T
     Metronomic Schedule of Paclitaxel Is Effective in Hormone Receptor-Positive and Hormone Receptor-Negative Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
157. GOODWIN PJ
     Vitamin D in cancer patients: above all, do no harm.
     J Clin Oncol. 2009;27:2117-9.
     PubMed     Text format     Related articles   
     
     
     
158. HILLNER BE , Smith TJ
     Efficacy does not necessarily translate to cost effectiveness: a case study in the challenges associated with 21st-century cancer drug pricing.
     J Clin Oncol. 2009;27:2111-3.
     PubMed     Text format     Related articles   
     
     
     April 2009
159. PENAULT-LLORCA F , Andre F, Sagan C, Lacroix-Triki M, et al
     Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor-Positive Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. ROSSI E , Morabito A, Di Rella F, Esposito G, et al
     Endocrine Effects of Adjuvant Letrozole Compared With Tamoxifen in Hormone-Responsive Postmenopausal Patients With Early Breast Cancer: The HOBOE Trial.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
161. BASELGA J , Semiglazov V, van Dam P, Manikhas A, et al
     Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor-Positive Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
162. DAI Q , Gao YT, Shu XO, Yang G, et al
     Oxidative Stress, Obesity, and Breast Cancer Risk: Results From the Shanghai Women's Health Study.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
163. TRIPATHY D
     Are We Hitting the Right Combination for Hormonally Sensitive Breast Cancer?
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
164. VERONESI U , Zurrida S, Goldhirsch A, Rotmensz N, et al
     Breast Cancer Classification: Time for a Change.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
165. ARNOULD L , Coudert B, Fumoleau P
     Is Immunohistochemestry Less Sensitive Than Quantitative Reverse Transcriptase Polymerase Chain Reaction for Hormone Receptor Status Determination in Breast Cancer?
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
166. JAHANZEB M
     Continuing trastuzumab beyond progression.
     J Clin Oncol. 2009;27:1935-7.
     PubMed     Text format     Related articles   
     
     
     
167. LIEDTKE C , Hatzis C, Symmans WF, Desmedt C, et al
     Genomic Grade Index Is Associated With Response to Chemotherapy in Patients With Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. BILIMORIA KY , Bentrem DJ, Hansen NM, Bethke KP, et al
     Comparison of Sentinel Lymph Node Biopsy Alone and Completion Axillary Lymph Node Dissection for Node-Positive Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
169. UNTCH M , Mobus V, Kuhn W, Muck BR, et al
     Intensive Dose-Dense Compared With Conventionally Scheduled Preoperative Chemotherapy for High-Risk Primary Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
170. KRISHNAN C , Moline S, Anders K, Warnke RA, et al
     Intravascular ALK-Positive Anaplastic Large-Cell Lymphoma Mimicking Inflammatory Breast Carcinoma.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
171. SCHONBERG MA , Silliman RA, Marcantonio ER
     Weighing the benefits and burdens of mammography screening among women age 80 years or older.
     J Clin Oncol. 2009;27:1774-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     
172. LU H
     FOXP3 expression and prognosis: role of both the tumor and T cells.
     J Clin Oncol. 2009;27:1735-6.
     PubMed     Text format     Related articles   
     
     
     
173. VAHDAT LT , Pruitt B, Fabian CJ, Rivera RR, et al
     Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
174. HALYARD MY , Pisansky TM, Dueck AC, Suman V, et al
     Radiotherapy and Adjuvant Trastuzumab in Operable Breast Cancer: Tolerability and Adverse Event Data From the NCCTG Phase III Trial N9831.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
175. CREW KD , Shane E, Cremers S, McMahon DJ, et al
     High Prevalence of Vitamin D Deficiency Despite Supplementation in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
176. COUTANT C , Olivier C, Lambaudie E, Fondrinier E, et al
     Comparison of Models to Predict Nonsentinel Lymph Node Status in Breast Cancer Patients With Metastatic Sentinel Lymph Nodes: A Prospective Multicenter Study.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
177. ANDERSON SJ , Wapnir I, Dignam JJ, Fisher B, et al
     Prognosis After Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Patients Treated by Breast-Conserving Therapy in Five National Surgical Adjuvant Breast and Bowel Project Protocols of Node-Negative Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
178. RABINOVITCH R , Kavanagh B
     Double Helix of Breast Cancer Therapy: Intertwining the Halsted and Fisher Hypotheses.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
179. DUNNE C , Burke JP, Morrow M, Kell MR, et al
     Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ.
     J Clin Oncol. 2009;27:1615-20.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2009
180. XENIDIS N , Ignatiadis M, Apostolaki S, Perraki M, et al
     Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
181. GIANNI L , Baselga J, Eiermann W, Porta VG, et al
     Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, as Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
182. REED SD , Li Y, Anstrom KJ, Schulman KA, et al
     Cost Effectiveness of Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
183. ZELLARS RC , Stearns V, Frassica D, Asrari F, et al
     Feasibility Trial of Partial Breast Irradiation With Concurrent Dose-Dense Doxorubicin and Cyclophosphamide in Early-Stage Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
184. MONTEMURRO F , Aglietta M, Del Mastro L
     Aromatase Inhibitors As Adjuvant Therapy for Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
185. CHEW HK , Doroshow JH, Frankel P, Margolin KA, et al
     Phase II Studies of Gemcitabine and Cisplatin in Heavily and Minimally Pretreated Metastatic Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
186. SROKOWSKI TP , Fang S, Hortobagyi GN, Giordano SH, et al
     Impact of Diabetes Mellitus on Complications and Outcomes of Adjuvant Chemotherapy in Older Patients With Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
187. HERSHMAN DL , Unger JM, Barlow WE, Hutchins LF, et al
     Treatment Quality and Outcomes of African American Versus White Breast Cancer Patients: Retrospective Analysis of Southwest Oncology Studies S8814/S8897.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
188. HASSETT MJ , Griggs JJ
     Disparities in Breast Cancer Adjuvant Chemotherapy: Moving Beyond Yes or No.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
189. MILLER WR , Larionov A, Renshaw L, Anderson TJ, et al
     Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole.
     J Clin Oncol. 2009;27:1382-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
190. TUTTLE TM , Jarosek S, Habermann EB, Arrington A, et al
     Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
     J Clin Oncol. 2009;27:1362-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
191. RECHT A
     Contralateral prophylactic mastectomy: caveat emptor.
     J Clin Oncol. 2009;27:1347-9.
     PubMed     Text format     Related articles   
     
     
     
192. AMIR E , Freedman O
     Underestimation of risk by Gail model extends beyond women with atypical hyperplasia.
     J Clin Oncol. 2009;27:1526.
     PubMed     Text format     Related articles   
     
     
     
193. SHIH YC , Xu Y, Cormier JN, Giordano S, et al
     Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up Study.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
194. STEINBACH S , Hummel T, Bohner C, Berktold S, et al
     Qualitative and Quantitative Assessment of Taste and Smell Changes in Patients Undergoing Chemotherapy for Breast Cancer or Gynecologic Malignancies.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
195. VON MINCKWITZ G , du Bois A, Schmidt M, Maass N, et al
     Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
196. SAUTER G , Lee J, Bartlett JM, Slamon DJ, et al
     Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations.
     J Clin Oncol. 2009;27:1323-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     
197. GONZALEZ KD , Noltner KA, Buzin CH, Gu D, et al
     Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
     J Clin Oncol. 2009;27:1250-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
198. JONES S , Holmes FA, O'Shaughnessy J, Blum JL, et al
     Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
     J Clin Oncol. 2009;27:1177-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
199. HUO D , Senie RT, Daly M, Buys SS, et al
     Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States.
     J Clin Oncol. 2009;27:1184-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
200. CHAN S , Romieu G, Huober J, Delozier T, et al
     Phase III Study of Gemcitabine Plus Docetaxel Compared With Capecitabine Plus Docetaxel for Anthracycline-Pretreated Patients With Metastatic Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
201. LENNON S , Barton C, Banken L, Gianni L, et al
     Utility of Serum HER2 Extracellular Domain Assessment in Clinical Decision Making: Pooled Analysis of Four Trials of Trastuzumab in Metastatic Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
202. LEARY AF , Hanna WM, van de Vijver MJ, Penault-Llorca F, et al
     Value and Limitations of Measuring HER-2 Extracellular Domain in the Serum of Breast Cancer Patients.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
203. MERLO A , Casalini P, Carcangiu ML, Malventano C, et al
     FOXP3 Expression and Overall Survival in Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
204. AMIR E , Seruga B, Freedman O, Tannock I, et al
     Lapatinib Plus Paclitaxel As First-Line Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Inappropriate Conclusions From a Company-Sponsored Study?
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
205. SMITH TJ
     Magnesium supplements for menopausal hot flashes.
     J Clin Oncol. 2009;27:1151-2.
     PubMed     Text format     Related articles   
     
     
     February 2009
206. MCARTHUR HL , Gelmon KA, Olivotto IA, Speers CH, et al
     Effectiveness of a Letter Notification Program for Women With Early-Stage Breast Cancer Eligible for Extended Adjuvant Letrozole.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
207. FIZAZI K , Lipton A, Mariette X, Body JJ, et al
     Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
208. BANDERA EV , August DA
     Alcohol Consumption and Breast Cancer Survival.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
209. RUSSELL NS , Kunkler IH, van Tienhoven G, Canney PA, et al
     Postmastectomy radiotherapy: will the selective use of postmastectomy radiotherapy study end the debate?
     J Clin Oncol. 2009;27:996-7.
     PubMed     Text format     Related articles   
     
     
     
210. PINCUS HA , Patel SR
     Barriers to the delivery of psychosocial care for cancer patients: bridging mind and body.
     J Clin Oncol. 2009;27:661-2.
     PubMed     Text format     Related articles   
     
     
     
211. WINER E , Gralow J, Diller L, Karlan B, et al
     Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
     J Clin Oncol. 2009;27:812-26.
     PubMed     Text format     Related articles    Abstract available
     
     
     
212. HUGH J , Hanson J, Cheang MC, Nielsen TO, et al
     Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
213. PARKER JS , Mullins M, Cheang MC, Leung S, et al
     Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
214. WATANABE T , Sano M, Takashima S, Kitaya T, et al
     Oral Uracil and Tegafur Compared With Classic Cyclophosphamide, Methotrexate, Fluorouracil As Postoperative Chemotherapy in Patients With Node-Negative, High-Risk Breast Cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
215. LE SCODAN R , Stevens D, Brain E, Floiras JL, et al
     Breast Cancer With Synchronous Metastases: Survival Impact of Exclusive Locoregional Radiotherapy.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
216. GIANNI L , Valagussa P
     Anthracyclines and Early Breast Cancer: The End of an Era?
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
217. SORLIE T
     Introducing Molecular Subtyping of Breast Cancer Into the Clinic?
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
218. ROUKOS DH
     Twenty-One-Gene Assay: Challenges and Promises in Translating Personal Genomics and Whole-Genome Scans Into Personalized Treatment of Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
219. MIN-HAN T , Seng TC, Yen LW
     Race to Report: Are Vascular Endothelial Growth Factor Genetic Polymorphisms Associated With Outcome in Advanced Breast Cancer Patients Treated With Paclitaxel Plus Bevacizumab?
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
220. THROCKMORTON AD , Esserman LJ
     When informed, all women do not prefer breast conservation.
     J Clin Oncol. 2009;27:484-6.
     PubMed     Text format     Related articles   
     
     
     
221. BERRY DA , Baines CJ, Baum M, Dickersin K, et al
     Flawed inferences about screening mammography's benefit based on observational data.
     J Clin Oncol. 2009;27:639-40.
     PubMed     Text format     Related articles   
     
     
     
222. SCHONBERG MA , McCarthy EP
     Mammography screening among women age 80 years and older: consider the risks.
     J Clin Oncol. 2009;27:640-1.
     PubMed     Text format     Related articles   
     
     
     January 2009
223. DANIELL HW
     Patient Characteristics and Prognosis in Metastatic Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
224. SNYDER CF , Frick KD, Kantsiper ME, Peairs KS, et al
     Prevention, Screening, and Surveillance Care for Breast Cancer Survivors Compared With Controls: Changes from 1998 to 2002.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
225. VINH-HUNG V , Verkooijen HM, Fioretta G, Neyroud-Caspar I, et al
     Lymph Node Ratio as an Alternative to pN Staging in Node-Positive Breast Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
226. ALEXANDER S , Minton O, Stone PC
     Evaluation of Screening Instruments for Cancer-Related Fatigue Syndrome in Breast Cancer Survivors.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
227. MAO JJ , Bowman MA, Stricker CT, Demichele A, et al
     Delivery of Survivorship Care by Primary Care Physicians: The Perspective of Breast Cancer Patients.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
228. SERUGA B , Tannock IF
     Up-Front Use of Aromatase Inhibitors As Adjuvant Therapy for Breast Cancer: The Emperor Has No Clothes.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
229. DANIELL HW
     Weight Loss After Breast Cancer Diagnosis May Not Improve Prognosis.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
230. KUERER HM , Albarracin CT, Yang WT, Cardiff RD, et al
     Ductal carcinoma in situ: state of the science and roadmap to advance the field.
     J Clin Oncol. 2009;27:279-88.
     PubMed     Text format     Related articles    Abstract available
     
     
     
231. CICCARESE M , Lorusso V
     How should we prescribe lapatinib to our patients: once daily or twice daily, and at what dose?
     J Clin Oncol. 2009;27:314-5.
     PubMed     Text format     Related articles   
     
     
     
232. BERGH J
     Quo vadis with targeted drugs in the 21st century?
     J Clin Oncol. 2009;27:2-5.
     PubMed     Text format     Related articles   
     
     
     
233. STENSHEIM H , Moller B, van Dijk T, Fossa SD, et al
     Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study.
     J Clin Oncol. 2009;27:45-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
234. FRANCIS PA
     Surprised by hope.
     J Clin Oncol. 2008;26:6001-2.
     PubMed     Text format     Related articles   
     
     
     
235. CRANDALL CJ
     Gene testing to predict tamoxifen-induced hot flashes: new biological insights.
     J Clin Oncol. 2008;26:5841-2.
     PubMed     Text format     Related articles   
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: